Table 1 of Gao, Mol Vis 2016; 22:234-242.

Table 1. Clinical features of the participants in this study.

ID Age
(yrs) Sex Disease status Age at onset (yrs) Visual
acuity Fundus appearance Color vision ERG OCT Visual field
II:2 68 M Aff 30s <0.1/0.2 PD, AA, MD,
POD BB Diminished Thinning PL and RPE;
Disrupted choroid visual field loss
II:3 63 M Aff 30s <0.1/0.1 PD, AA, MD,
POD BB Diminished Thinning PL and RPE;
Disrupted choroid visual field loss
III:2 48 F Aff 20s <0.1/0.1 PD, AA, MD,
POD BB Not examined Thinning PL and RPE;
Disrupted choroid Not examined
III:3 43 F Un - Not examined No obvious RP symptoms Normal Normal Not examined Normal
III:4 40 M Aff 20s <0.1/0.1 PD, AA, MD,
POD BB Not examined Thinning PL and RPE;
Disrupted choroid visual field loss
III:5 39 F Un - Not examined No obvious RP symptoms Normal Normal Normal Not examined
III:7 34 M Aff 10s LP PD, AA, MD,
POD BB Diminished Thinning PL and RPE;
Disrupted choroid visual field loss
III:10 26 M Un - Not examined No obvious RP symptoms Normal Normal Normal Normal
III:11 21 F Aff 20s Not examined No obvious RP symptoms Normal Diminished rod response, normal cone response Normal Normal
III:15 31 F Aff 20s <0.2/0.2 PD, AA, MD,
POD BB Not examined Thinning PL and RPE;
Disrupted choroid Not examined

Abbreviations: M: male; F: female; Aff: affected; Un: unaffected; ERG: electroretinography; LP: light permission; OCT: optical coherence tomography; PD: pigment deposition; AA: attenuated retinal arterioles; MD: macular degeneration; POD: pale optic discs; BB: blue color blindness; PL: photoreceptor layer; RPE: retinal pigment epithelium

Gao, Mol Vis 2016; 22:234-242. http://www.molvis.org/molvis/v22/234

©2016 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535